Period Ending: |
LTM
(Last Twelve Months) |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
2018 12-31 |
2017 12-31 |
---|---|---|---|---|---|---|---|---|
Report Filing | 2024-04-26 | 2023-03-20 | 2022-05-02 | 2021-03-18 | 2020-03-27 | 2018-12-31 | 2017-12-31 | |
Revenue | 93.6 | 69.8 | 54.6 | 64.0 | 116 | 136 | 59.0 | |
Cost of Revenue | 74.3 | 58.2 | 48.2 | 48.8 | 81.7 | 87.6 | 38.7 | |
Gross Profit | 19.3 | 11.6 | 6.41 | 15.2 | 34.5 | 48.1 | 20.3 | |
Operating Expenses | 18.8 | 25.9 | 44.4 | 42.9 | 56.2 | 42.7 | 27.1 | |
Research & Development | 1.77 | 7.97 | 17.7 | 16.2 | 26.1 | 23.2 | 13.0 | |
Selling, General and Administrative | 17.0 | 17.9 | 26.7 | 26.7 | 30.1 | 19.4 | 14.1 | |
Other Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating Income | 0.51 | -14.3 | -38.0 | -27.7 | -21.6 | 5.39 | -6.77 | |
Net Non-Operating Interest | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | -1.83 | -0.82 | |
Interest Income | 0.00 | 0.10 | 0.00 | 0.76 | 1.52 | 0.00 | 0.00 | |
Interest Expense | 0.02 | 0.10 | 0.00 | 0.76 | 1.52 | 1.83 | 0.82 | |
Equity & Other Income/(Expense) | -0.21 | 0.39 | -0.46 | -2.74 | -2.80 | -1.54 | -0.80 | |
Income Before Tax | 0.28 | -13.9 | -38.5 | -30.5 | -24.4 | 2.03 | -8.38 | |
Income Tax Expense | 0.37 | 0.18 | 0.17 | -0.52 | 1.39 | 0.75 | 0.13 | |
Income Attributable to Non-Controlling Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Income | -0.09 | -14.1 | -38.6 | -29.9 | -25.8 | 1.28 | -8.52 | |
Depreciation and Amortization | 2.21 | 0.66 | 2.13 | 2.73 | 3.52 | 1.85 | 1.32 | |
EBITDA | 2.72 | -13.6 | -35.9 | -25.0 | -18.1 | 7.24 | -5.45 | |
Earnings Per Share (EPS) | -0.022 | -0.490 | -4.080 | -6.480 | -13.89 | 0.650 | -4.370 | |
Diluted Earnings Per Share | -0.022 | -0.490 | -4.080 | -6.480 | -13.89 | 0.650 | -4.370 | |
Weighted Average Shares Outstanding | 4.17 | 28.9 | 9.46 | 4.62 | 1.86 | 1.95 | 1.95 | |
Diluted Weighted Average Shares Outstanding | 4.17 | 28.9 | 9.46 | 4.62 | 1.86 | 1.95 | 1.95 |